Posts

Health related Innovation, Incentivization and IPR for Post- Covid World – A vision for the South

Krishna Ravi Srinivas, PhD Consultant, RIS The concept paper for the Webinar ‘South-South Co-operation on IPRS for Access to Health in the times of Pandemics’ held on 20 th November 2020 outlines the various issues, challenges, and policy options available to the South in the context of intellectual property and innovation in a post-COVID-19 world.   The paper obviously gives importance to South-South co-operation. But it goes beyond that stating “Can the South put its collective strength together and develop licenses and mechanism that are more suited to South?” and follows that with 12 guiding ques tions which need serious reflection. In this blog post based on my talk given in the webinar I discuss one aspect and suggest that South should think in terms of collective self-reliance and work for it. The literature points out how countries have used various options available to them, including the flexibilities in TRIPS (Trade Related Intellectual Property Rights) Agreement. But t

Strategic Partnership between India and Argentina towards a New World Order in the Post COVID World

Prativa Shaw Research Assistance, RIS   The COVID-19 pandemic in 2020 has not only created a frightening litany of challenges but also created an opportunity to turn the threat to rewrite the future to become more equitable, sustainable and inclusive. The year 2020 is very stressful and struggling time to get through for the poor who are getting poorer with up to 90 million people pushed into extreme poverty and global growth contracted by 4.4 per cent in 2020 (IMF projection). However, some rays of hope can be seen with some success in vaccine development, but access to vaccines for all is one of the biggest challenges. It is important that the world cooperates and coordinates to build a more resilient and sustainable future with concrete actions, rapid innovation, and cross-sector partnership for scaling production of goods, protecting jobs and providing food to the most vulnerable. To discuss some of these issues, prominent think tanks from India and Argentina came together on

Non-Tariff Measures in East Asia

Ms Chandni Dawani Research Assistant, RIS In current challenging economic situation posed by COVID-19 pandemic and increasing uncertainties of trade policies, it needs to be emphasized more than ever on the importance of strengthening economic integration by removing unnecessary barrier to trade. Tariffs (taxes on imported goods) have declined in number and in magnitude as FTA’s have proliferated around the world. However, while tariffs have been declining, NTMs have increased. NTMs are policy measures other than ordinary tariffs that can have economic effect on international trade affecting the quantities traded or prices or both [1].   Considering the phenomenal rise in NTMs and their impact on international trade, they have received much attention particularly by the academicians and trade policymakers. Recently, an online policy dialogue was conducted by the Economic Research Institute for ASEAN and East Asia (ERIA) and UNCTAD on 8 th December to discuss issues related to Non-

Cost of Brexit Transition and Spillovers to Developing Countries

  Ms.   Sonal Garg, Research Assistant & Dr. Priyadarshi Dash, Assistant Professor   UK exited the European Union in the first month of 2020 and entered into an 11-month transition period, which allows it to follow Union’s rules and maintain the status quo until a new deal is struck between the two entities. The 11-month period, the purpose of which was to provide a window of opportunity to both the parties to negotiate various aspects of a future agreement, expires on 31 st December 2020 following which UK will lose its ties and forgo its membership of the European Union.  EU’s level of access to UK waters, state-aid, trade deal, Irish border issue and dispute settlement mechanism are some of the contentious yet important issues that remain to be negotiated. [i] As the transition period is nearing its end, it has become imperative for the two parties to fast-track their dialogue.   If both the parties fail to sign an agreement that clearly stipulates the rules and standards

Global Development Centre (GDC) at RIS: Promoting Sustainable Development through Demonstration and Dialogue

Mr Abhinav Jha Policy Manager, GDC Established at RIS, the GDC aims to contribute to the evolving alternative development paradigm and promotes the virtues of inclusiveness and sustainability. With deeper understanding of theories and practices, GDC intends to promote newly acquired knowledge from India’s successful programmes and initiatives among partner countries in Asia, Africa and Latin America, and facilitate learning from other country experiences through empirical research, sharing of skills, expertise and best practices, and exchange of human resources. Started in 2019, the GDC has implemented a set of important activities to advance its core objectives, including the publication of the Development Cooperation Review, GDC Fellowship Programmes, meetings with policy leads and Line Ministries, to forge and consolidate links with partner countries and institutions. As the COVID pandemic paralyzed physical interactions, GDC adopted the digital path to reach out to constituents i

Nobel Prize for CRISPR

  Dr. Sneha Sinha   Research Associate, RIS Two scientists, Emmanuelle Charpentier and Jennifer Doudna were recently awarded Nobel Prize in Chemistry for the development of a gene manipulating technology. Though genetic research has advanced enormously in the last 50 years, the revolutionary ‘Clustered, Regularly Interspaced, Short  Palindromic Repeats’ in association with the Cas9 DNA-cutting enzyme (CRISPR/Cas9 genetic scissors) is ‘one of gene technology’s sharpest tools for re-writing the code of life’. [1] Its discovery can be traced to the efforts of Japanese scientists at Osaka University, who in 1987 noticed an aberrant pattern of DNA sequence, followed by tremendous incremental research . In 2011, these two scientists jointly initiated the investigation of the Cas9 enzyme. [2] CRISPR allows targeted changes in the genetic material by removing, replacing or adding more than one segments of DNA at a time in plants, animals and humans. [3] There is consensus among scienti